Global Health Tuesday: Global Health Grant Trends

We welcome you to join us for GHI’s next Global Health Tuesday Webinar on Tuesday, February 20, from 9-10am, when UW–Madison Global Health Institute Director Jorge Osorio leads the conversation on global health grant trends.

Panelists include Chris Karp, M.D., and Peter Kilmarx. Click here to view the session recording on GHI’s YouTube.

You may also find presenter slides with these links: Chris Karp and Peter Kilmarx.

Meet the Moderator:

headshot of UW-Madison GHI Director Jorge Osorio

GHI Director Jorge Osorio, DVM, Ph.D., M.S., is a professor in the Department of Pathobiological Sciences in the School of Veterinary Medicine. Osorio has had a lengthy career in medical sciences, including virology, field epidemiological studies, vaccinology, antivirals and vector control programs. He is also the co-director of a Colombia-Wisconsin One Health Consortium, a joint effort between the University of Wisconsin and Universidad Nacional in Colombia that is studying emerging diseases and one-health issues. Osorio recently founded VaxThera, a Colombian-based company that will produce vaccines and biologicals for Colombia and the region. He was also a co-founder and chief Scientific officer of Inviragen, a biotechnology company that developed a novel chimeric tetravalent dengue vaccine that recently completed successfully Phase 3 clinical trials. He also developed vaccines against chikungunya, influenza, rabies, plague and many other emerging infectious diseases.

Osorio also has served as vice president of Research and vice president of Government Affairs for the Vaccine Business Division of Takeda Pharmaceuticals. His industry career also included positions at Heska Corporation (Ft. Collins, Colorado), Merial LTD (Athens, Georgia), and Chiron-Powderject Vaccines (Madison, Wisconsin). He has more than 30 years of research and industry experience with more than 130 scientific publications in international journals and 32 patents.

Meet the Panelists:

Chris Karp, M.D. is the Director of Global Health Discovery & Translational Sciences at the Bill & Melinda Gates Foundation, a team whose mission is to catalyze innovation for the discovery and translation of transformative solutions to global health and development inequity.

An immunologist, infectious diseases specialist, and internist, Chris joined the foundation in 2012 as deputy director, Vaccines & Host-Pathogen Biology on the Global Health Discovery & Translational Sciences team. Prior to the foundation, he was on the faculty of the departments of Medicine and Molecular Microbiology & Immunology at Johns Hopkins University School of Medicine and founded the division of Molecular Immunology at Cincinnati Children’s Hospital Research Foundation, where he was Esiason/Bell Professor of Pediatrics. His academic scientific career focused on defining the mechanisms underlying the regulation and dysregulation of inflammatory responses in infectious, allergic, and genetic diseases, with a focus on diseases of children.

Chris received an undergraduate degree (summa cum laude, with high honors in philosophy) from Brandeis University and an M.D. from the University of North Carolina School of Medicine, where he was a Morehead Fellow. He trained in medicine at Brown University and Georgetown University, and then was an NRSA fellow in the Laboratory of Parasitic Diseases at NIAID, and an infectious diseases fellow atJohns Hopkins.

A violinist and pianist, he often joins the Faculty Music Series and the University of Wisconsin-Madison, performing with his brother Parry Karp, ‘cellist of the Pro Arte Quartet.

Dr. Peter Kilmarx is Acting Director of the Fogarty International Center and Acting Associate Director for International Research at the National Institutes of Health. He joined Fogarty as Deputy Director on July 1, 2015, and assumed his current roles on January 15, 2023.

Dr. Kilmarx is an expert on infectious disease research and HIV/AIDS prevention. During his tenure at Fogarty he has led analysis of NIH global health activities, built coalitions with high-level NIH and external stakeholders, and represented the Center and NIH in national and international forums. He co-lead an initiative to transform African health professional education and research, resulting in the formation of the African Association for Health Professions Education and Research (AFREHealth), as well as the African Postdoctoral Training Initiative (APTI), which brings African postdoctoral fellows to NIH. He has also focused on efforts to increase equity in global health research and build global capacity for pandemic preparedness .

He previously served as the Center for Disease Control and Prevention’s Country Director in Zimbabwe, providing oversight for 30 CDC staff who managed implementation of the U.S. efforts to reduce HIV/AIDS, tuberculosis (TB), and malaria. A retired Rear Admiral and Assistant Surgeon General in the U.S. Public Health Service, Dr. Kilmarx served as the CDC Ebola response team leader in Sierra Leone in September-October 2014, and as principal deputy team leader in Guinea in January-February 2015. Previously, he initiated the CDC response to the Ebola outbreak in Kasai Occidental, Democratic Republic of Congo (DRC), in 2007, and led household surveillance in the Ebola outbreak in Kikwit, DRC, in 1995.